Acasti Pharma Stock Price (NASDAQ:ACST)

Add to My Stocks
$0.49 $0.01 (2.08%) ACST stock closing price Aug 21, 2018 (Closing)
Prev Close* : $0.48
Market Cap:
Day Low: $0.45
52 Week Low: $0.43
Open: $0.48
Volume: -
Day High: $0.5
52 Week High: $3.36

Latest Stock Market News

Latest Articles

Acasti Pharma News - From Partners

ACST Stockcharts

View ACST PE ratio, PS ratio stocks charts and compare with peers.
ACST Chart
Note: Compare Acasti Pharma stock price history with the index and industry peers.

Acasti Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Acasti Pharma Returns

(return on equity)

Acasti Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

ACST Industry Peers

Company Price Change (%)
Evoke Pharma (EVOK)2.430.05 (2.1%)
Pernix Therapeutics (PTX)1.490.07 (4.93%)
Catabasis Pharma (CATB)0.650.01 (1.56%)
Astrazeneca (AZN)38.760.09 (0.23%)
Glaxosmithkline (GSK)41.50.17 (0.41%)
Abbvie (ABBV)97.740.11 (0.11%)
Ionis Pharma (IONS)53.251.58 (3.06%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Corium (CORI)9.170.28 (3.15%)
Progenics Pharma (PGNX)7.910.24 (3.13%)
Adamas Pharma (ADMS)22.410.57 (2.61%)
Teligent (TLGT)4.350.09 (2.11%)
Mylan (MYL)38.750.34 (0.89%)
Dr. Reddy's Laboratories (RDY)34.50.28 (0.82%)
BAUSCH HEALTH (BHC)22.370.05 (0.22%)
Top gainers from Medical-Generic Drugs industry
* As of Aug 21, 2018
CompanyPriceChange (%)
Akorn (AKRX)17.921.56 (8.01%)
Teva Pharmaceutical (TEVA)25.170.48 (1.87%)
Mallinckrodt (MNK)35.970.1 (0.28%)
Supernus Pharma (SUPN)44.350.05 (0.11%)
Top losers from Medical-Generic Drugs industry
* As of Aug 21, 2018

Acasti Pharma Inc Stock News - Partner Headlines

Acasti Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues-----
Net Income-7.99M-4.84M-1.47M-11.11M-6.9M
Total Operating Expense7.99M7.33M11.06M10.53M7.3M
View Acasti Pharma income statement
balance sheet2016201520142013
Total Assets16.27M23.43M34.9M24.53M
Total Liabilities1.37M1.43M3.24M4.78M
Shareholders Equity14.9M21.99M31.66M19.74M
View Acasti Pharma balance sheet
cash flow statement2016201520142013
Net Increase (Decrease) in Assets Liabilities--1.49M2.43M
Net Cash from (used by) Operating Activities-3.6M-3.69M-4.09M-2M
Increase (Decrease) in Prop Plant And Equipment-1.33M-0.16M-0.03M-
View Acasti Pharma cash flow statement

Acasti Pharma Stock Message Board

Acasti Pharma stock price ended the last trading day at $0.49. The total market value as denoted by $16.85M for Acasti Pharma, is the market value of the company's outstanding shares. Acasti Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Acasti Pharma is worth a lot, it will most likely be reflected in an inflated Acasti Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 66,512 ACST shares were traded yesterday, and Acasti Pharma stock chart shows that the ACST stock quote hit a day high of $0.5 and day low of $0.45. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Acasti Pharma stock dividend was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Acasti Pharma stock price history.